Safety and Efficacy of Sirolimus-Eluting Stent in Diabetic Patients Compared with Non-Diabetic Patients Undergoing Percutaneous Coronary Intervention

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.12970/2311-052X.2014.02.01.5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I

  2013cited by this paper
• A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial.

  2011cited by this paper
• Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).

  2010cited by this paper
• Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting

  2010cited by this paper
• A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus.

  2008cited by this paper
• Drug-Eluting Stents: Preventing Restenosis

  2007cited by this paper
• Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.

  2007cited by this paper
• One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease.

  2006cited by this paper
• Drug-eluting stents for diabetes mellitus: a rush to judgment?

  2005cited by this paper
• New aspects in the pathogenesis of diabetic atherothrombosis.

  2004cited by this paper
• Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study.

  2002cited by this paper
• Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group.

  2001cited by this paper
• Diabetes and cardiovascular disease

  2000cited by this paper
• Diffuse Narrowing of Coronary Arteries in Diabetic Patients: The Earliest Phase of Coronary Artery Disease

  1998cited by this paper
• Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement.

  1998cited by this paper
• Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study.

  1997cited by this paper
• Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.

  1996cited by this paper
• Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.

  1995cited by this paper
• Can restenosis after coronary angioplasty be predicted from clinical variables?

  1993cited by this paper
• Repeat coronary angioplasty for restenosis: results and predictors of follow-up clinical events.

  1989cited by this paper
• Risk factors for recurrent stenosis following successful coronary angioplasty.

  1989cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper

• Clinical Outcomes of Successful Sirolimus-Eluting Stent Implantation in Patients with Chronic Total Occlusion in the Real Clinical Practice

  2019cites this paper
• Clinical performance of biodegradable polymer coated Sirolimus-eluting stent in multivessel disease: Results from MULTIDES study

  2016cites this paper
• Clinical Outcomes from Unselected “Real-World” Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent

  2015cites this paper